 |
Evolving Concepts in the Management of Thrombocytopenia in Patients With Leukemia CME/CE Author Information and Disclosures Release Date: January 28, 2008; Valid for credit through January 28, 2009 | Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians;
Nurses - 1.0 nursing contact hours (0.5 contact hours are in the area of pharmacology);
Pharmacists - 1.0 ACPE continuing education credits for pharmacists (0.1 CEUs) | | The content of this CME activity, "Evolving Concepts in the Management of Thrombocytopenia in Patients With Leukemia," was developed by the faculty.
To participate in this activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details. Contents of This CME/CE Activity- Management of Thrombocytopenia in Patients With LeukemiaThis Expert Column details current management strategies for thrombocytopenia -- a common and significant problem in patients with leukemia -- as well as potential new treatment approaches.Arafat Tfayli, MD; James George, MD (Expert Column, January 28, 2008)
- Platelet Transfusion and Beyond for the Treatment of Thrombocytopenia in Patients With Leukemia: An Expert Interview With Dr. Daniel J. WeisdorfDr. Daniel J. Weisdorf discusses the role of platelet transfusion and the criteria that newer treatments must satisfy to be of value in the treatment of thrombocytopenia in leukemia.Daniel J. Weisdorf, MD (Expert Interview, January 28, 2008)
- Thrombocytopenia in Acute LeukemiaDr. Mikkael A. Sekeres reviews the recent literature regarding thrombocytopenia in patients with leukemia.Mikkael A. Sekeres, MD, MS (Journal Scan, January 28, 2008)
Legal DisclaimerThe material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2008 Medscape. |
|
|
Learning Objectives Upon completion of this activity, participants will be able to: - Describe the epidemiology of thrombocytopenia associated with leukemia
- Discuss the advantages and disadvantages of platelet transfusion for the treatment and/or prevention of thrombocytopenia in patients with leukemia
- Cite currently available data about the mechanism of action, safety, and efficacy of thrombopoiesis-stimulating proteins and other investigational treatments for thrombocytopenia
Authors and Disclosures Arafat Tfayli, MD
Disclosure: Arafat Tfayli, MD, has disclosed no relevant financial relationships.
James N. George, MD
Disclosure: James N. George, MD, has disclosed that he has received grants for clinical research and served as an advisor or consultant to Amgen. Daniel J. Weisdorf, MD
Disclosure: Daniel J. Weisdorf, MD, has disclosed that he has received research support from Amgen, Cephalon, Genzyme, Mayne, Merck, Roche, and Supergen, and has served as a consultant to Dor,
Exelis, Schering Plough, and Therakos. Mikkael A. Sekeres, MD, MS
Disclosure: Mikkael A. Sekeres, MD, MS, has disclosed that he has received grants for clinical research from Celgene. Dr. Sekeres has also disclosed that he has received grants for educational activities from Celgene and Pharmion. Margie Miller
Disclosure: Margie Miller has disclosed no
relevant financial relationships. Jill W. Chamberlain
Disclosure: Jill W. Chamberlain has disclosed no relevant financial relationships. |
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
This Activity is sponsored by Medscape Continuing Education Provider Unit. Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 0.5 contact hours are in the area of pharmacology. Provider Number: 6FDKKC-PRV-05
Contact This Provider
|
|
 Medscape is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Medscape designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) (Universal Program Number 461-000-08-005-H01-P).
Contact This Provider
|
|
